GI/endoscopy company stock report – April 17

Here is a stock report on five publicly traded GI/endoscopy companies for April 13 to April 17.

Advertisement

•    AbbVie: $62.29 per share (down 0.48 percent)
•    Boston Scientific: $18.26 per share (up 0.58 percent)
•    FUJIFILM Holdings: $38.56 per share (up 0.56 percent)
•    Olympus: $36.90 per share (down 1.13 percent)
•    Valeant Pharmaceuticals: $204.50 per share (down 1.38 percent)

More articles on gastroenterology:
CMS: Guidance on colonoscopy anesthesia modifier, X modifiers
Alternative payment models in GI: What’s on the horizon?
3 GI physicians making headlines – April 17, 2015

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.